The method of embodiment90, wherein the JNK inhibitor is selected from minocycline
This opens the possibility of oral administration, which is particularly relevant for gastrointestinal autoimmune conditions where delivering the peptide directly to the affected tissue makes biological sense
Current research regarding the peptide focuses on the ability of the compound to effect proliferative activity and resulting heat sensitivity throughout various cell samples Main Research Findings 1) Treatment with Goralatide has the potential to enhance the selectivity of hyperthermic purging in human progenitor cells
Obviously this ignores all those who require life long treatment due to other causes of B12 deficiency (of which there are many), thereby potentially causing great harm to the vast majority of their B12 deficient patients
Shanghai Yieryi Biotechnology Co., A method for synthesizing GHK tripeptide, Shanghai Yieryi Biotechnology Co., Ltd., China
Digestive Health Peptide Therapy What is peptide therapy used for